[Adjuvant therapy during the administration of GnRH agonists].
Nikolov
A
A
Kolarov
G
G
D000277:Adjuvants, Pharmaceutic / Q000627:therapeutic use*; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000188:drug therapy; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists* / Q000031:analogs & derivatives; D017273:Goserelin / Q000627:therapeutic use*; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy; D011293:Premenstrual Syndrome / Q000188:drug therapy; D014592:Uterine Hemorrhage / Q000188:drug therapy
D000277:Adjuvants, Pharmaceutic; D018931:Antineoplastic Agents, Hormonal; D017273:Goserelin; D007987:Gonadotropin-Releasing Hormone
Dopŭlvashta terapiia pri izpolzvane na GnRH--agonisti.